Trial Details
COMPLETEDBasic Information
| Clinical ID | c2941 |
|---|---|
| Identifier | NCT02757105 |
| Trial Title | Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome With Diarrhea |
| Interventions | DRUG: BEKINDA|DRUG: Placebo |
Participant Information
| Sponsor | RedHill Biopharma Limited |
|---|---|
| City | Huntsville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2016-05-19 |
|---|---|
| Primary Completion Date | 2017-06-16 |
| Completion Date | 2017-07-14 |